ProEncia Pipeline

ProEncia has developed a line of patent-pending, non-invasive, topical products that prevent, protect, reverse and repair progressive deterioration and atrophy associated with periodontal diseases, gingivitis.

These products treat the entire spectrum of the disease, from preventing periodontal diseases from taking root among healthy population, to treating and reversing severe destructive periodontitis disease states.

Based on our outstanding clinical outcome we now also advancing towards licensing and commercialization of our products.

OTC Solutions

ProEncia OTC products are daily topical applications with two primary aims.

First, to support tissue repair, strengthen the dental foundation which includes dental root ligaments and the alveolar bone, and to help deter progression of chronic periodontal diseases.  

Second, to provide all-day protection against pathogenic bacteria, which involves impeding bacterial attachment to dental surface, growth, and plaque buildup - thus preventing and protecting against the mouth’s daily pathogen invasion. 

PNP-101 is aimed as a prophylactic to prevent periodontal diseases from taking root among healthy individuals.

PNC-101 is for patients with periodontal diseases, as it reverses the disease state and prevents disease relapse.

RX Solutions

ProEncia RX products are for short term applications, in both acute and chronic periodontal gum disease cases. 

This line of products help fight infections via clearing of the supragingival and subgingival pathogenic bacterial load, and help facilitate system repair and damage control in the host. They aim to deliver far higher efficacy and accessibility than other methods currently on the market.

In addition, these products can be applied as adjunct therapy following root canals, SRP (root scaling and planing), and other more invasive procedures, which may yield faster results and better recovery.